Minimizing Carry-Over Effects After Treatment Failure and Maximizing Therapeutic Outcome
Can Changing the Route of Administration Mitigate the Influence of Treatment History?
Abstract
According to experimental and clinical evidence, the experiences of previous treatments are carried over to different therapeutic approaches and impair the outcome of subsequent treatments. In this behavioral pilot study we used a change in administration route to investigate whether the effect of prior treatment experience on a subsequent treatment depends on the similarity of both treatments. We experimentally induced positive or negative experiences with a topical analgesic treatment in two groups of healthy human subjects. Subsequently, we compared responses to a second, unrelated and systemic analgesic treatment between both the positive and negative group. We found that there was no difference in the analgesic response to the second treatment between the two groups. Our data indicate that a change in administration route might reduce the influence of treatment history and therefore be a way to reduce negative carry-over effects after treatment failure. Future studies will have to validate these findings in a fully balanced design including larger, clinical samples.
References
(2011). On the importance of placebo timing in rTMS studies for pain relief. Pain, 152, 1233–1237. doi: 10.1016/j.pain.2010.12.027
(1968). Placebo responsiveness – influence of previous therapy. Current Therapeutic Research, Clinical and Experimental, 10, 136–143.
(2005). Is acupuncture analgesia an expectancy effect? Preliminary evidence based on participants’ perceived assignments in two placebo-controlled trials. Evaluation & the Health Professions, 28, 9–26. doi: 10.1177/0163278704273081
(2011). The effect of treatment expectation on drug efficacy: Imaging the analgesic benefit of the opioid remifentanil. Science Translational Medicine, 3, 70ra14 doi: 10.1126/scitranslmed.3001244
(2006). How prior experience shapes placebo analgesia. Pain, 124, 126–133. doi: 10.1016/j.pain.2006.04.005
(2004). Overt versus covert treatment for pain, anxiety, and Parkinson’s disease. Lancet Neurology, 3, 679–684. doi: 10.1016/S1474-4422(04)00908-1
(1976). Method for quantitative estimation of thermal thresholds in patients. Journal of Neurology, Neurosurgergy, and Psychiatry, 39, 1071–1075.
(1993). ADS Allgemeine Depressionsskala
[General depression scale] . Göttingen, Germany: Beltz Test.(1999). The beliefs about medicines questionnaire: The development and evaluation of a new method for assessing the cognitive representation of medication. Psychology & Health, 14(1), 1–24. doi: 10.1080/08870449908407311
(2013). The effect of treatment history on therapeutic outcome: An experimental approach. JAMA Internal Medicine, 173, 1468–1469. doi: 10.1001/jamainternmed.2013.6705
(2007). The impact of patient expectations on outcomes in four randomized controlled trials of acupuncture in patients with chronic pain. Pain, 128, 264–271. doi: 10.1016/j.pain.2006.12.006
(1997). Classical conditioning and the placebo effect. Pain, 72, 107–113.
(2001). Response expectancies in placebo analgesia and their clinical relevance. Pain, 93, 77–84.
(1977). The CES-D scale a self-report depression scale for research in the general population. Applied Psychological Measurement, 1, 385–401.
(1987). Toward a universal law of generalization for psychological science. Science, 237, 1317–1323.
(1983). Foreword [Special Issue: Behavioral Medicine]. International Review of Applied Psychology – Revue Internationale De Psychologie Appliquee, 32, 1–4.
(1992). Classic conditioning and placebo effects in crossover studies. Clinical Pharmacology and Therapeutics, 52, 372–377.
(1985). Conditioned placebo responses. Journal of Personality and Social Psychology, 48, 47–53.
(1990). The role of conditioning and verbal expectancy in the placebo response. Pain, 43, 121–128.
(2004). Placebo-induced changes in fMRI in the anticipation and experience of pain. Science, 303, 1162–1167. doi: 10.1126/science.1093065
